| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/27/2000 | CA2337880A1 Substituted piperazinones and therapeutic uses thereof |
| 01/27/2000 | CA2337850A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | CA2337838A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | CA2337776A1 Bispiperidines as antithrombotic agents |
| 01/27/2000 | CA2337517A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | CA2337507A1 Composition for treatment of stress |
| 01/27/2000 | CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
| 01/27/2000 | CA2337256A1 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | CA2337194A1 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | CA2337179A1 Therapeutic composition based on flavonoids, intended to be used in the treatment of tomours by cytotoxic |
| 01/27/2000 | CA2337138A1 Compositions and methods of treating abnormal cell proliferation |
| 01/27/2000 | CA2337115A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | CA2336950A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2334075A1 Bone morphogenic protein |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
| 01/26/2000 | EP0973901A2 Flip gene and flip protein |
| 01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
| 01/26/2000 | EP0973888A1 Dendritic cell-derived growth factor |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973801A1 GnRH ANTAGONISTS |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973778A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/26/2000 | EP0973777A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 01/26/2000 | EP0973775A1 Pyrolopyrrolone derivatives |
| 01/26/2000 | EP0973773A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
| 01/26/2000 | EP0973772A1 Compounds |
| 01/26/2000 | EP0973769A1 Process for preparing eprosartan |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973753A2 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| 01/26/2000 | EP0973749A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973746A1 Substituted 3-cyano quinolines |
| 01/26/2000 | EP0973743A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 01/26/2000 | EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973738A1 Novel heterocyclic compounds |
| 01/26/2000 | EP0973732A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivatives, process for their preparation and their use as pharmaceuticals |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973539A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/26/2000 | EP0973532A1 Anti-proliferative preparations |
| 01/26/2000 | EP0973531A1 Facilitation of wound healing with cm101/gbs toxin |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | EP0973529A2 Essential oil composition |
| 01/26/2000 | EP0973522A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 01/26/2000 | EP0973517A1 Antithrombotic agents |
| 01/26/2000 | EP0973515A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 01/26/2000 | EP0973500A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0927030A4 Use of aryl n-substituted carboxamides to kill tumors |
| 01/26/2000 | EP0791006B1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | EP0763016B1 Compositions and methods for treating mast-cell mediated conditions |
| 01/26/2000 | EP0686145B1 New compounds |
| 01/26/2000 | EP0670839B1 Process for the preparation of 9-amino camptothecin |
| 01/26/2000 | EP0650484B1 Endothelin receptor antagonists |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | CN1242772A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1242237A Dietetic food composition and dietetic method using such composition |
| 01/26/2000 | CN1048727C Process for prepn. of 2-(1-azabicyclo (2,2,2) oct-3-yl)-2,4,5,6-tetrahydro-1H-benz |
| 01/26/2000 | CN1048726C Substituted 4-phenyl thiazole derivant, prepn. and medicine compositions thereof |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 01/25/2000 | US6017964 Administering to a male patient droloxifene or it's derivatives know as an antiestrogenic agent |
| 01/25/2000 | US6017945 Useful in the treatment of restenosis, renal failure and pulmonary hypertension |
| 01/25/2000 | US6017932 Pharmaceutical compositions containing at least one NSAID having increased bioavailability |
| 01/25/2000 | US6017929 Cholinesterase activator |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017927 Quinuclidine derivatives and medicinal composition thereof |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/25/2000 | US6017909 Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/25/2000 | US6017907 Structural analogues of vitamin D |
| 01/25/2000 | US6017904 Steroid sulphatase inhibitors |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017888 Stimulation of hair growth by peptide copper complexes |
| 01/25/2000 | US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017876 Monosuccinylated exclusively a n-terminus |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
| 01/25/2000 | US6017534 Development of transgenic plants which express broad-spectrum insecticidal activity against a variety of flies, moths and beetles; chimeric crystal delta-endotoxins having improved insecticidal properties and broad-range specificities |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/25/2000 | CA2205546C Oral compositions containing ondansetron |
| 01/25/2000 | CA2184005C Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/25/2000 | CA2163904C Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 01/25/2000 | CA2001436C Carboxylic acid derivatives |
| 01/20/2000 | WO2000003248A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | WO2000003244A2 Immortalized human keratinocyte cell line |